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U
ntreated human immunodeﬁciency virus (HIV)
infection in humans is typically characterised by
persistent high virus load, failure of the immune
response to clear the virus, and fatal disease outcome. Natural
hosts of closely related simian immunodeﬁciency viruses
(SIVs)—e.g., sooty mangabeys [1,2]—maintain comparably
high persistent virus levels and yet remain healthy. These
contrasting observations have two important implications.
First, the virulence (disease-causing ability) of HIV is not an
inevitable consequence of its massive replication in the
infected hosts. SIVsm, the virus of sooty mangabeys, can
replicate to high levels without any discernible effect on the
host. The prevalence of SIV infection among wild-living sooty
mangabeys can exceed 50% [3], which is also consistent with
nonpathogenic infection. The direct metabolic cost of virus
production must therefore be small, and disease in HIV
infection cannot be explained by a simple diversion of host
resources to virus production. Second, sooty mangabeys do
not avoid disease by controlling the virus to low levels. While
humans with HIV and macaques experimentally infected with
SIVsm mount a vigorous T cell response that can temporarily
suppress virus replication, sooty mangabeys display hardly
any T cell proliferation upon infection [4], and allow high
levels of virus replication from the beginning of the infection.
Instead of eliminating the direct effects of infection by
suppressing the virus, they can apparently avoid the indirect
effects that are responsible for disease in HIV infection.
The clinical progression of HIV infection is characterised
by a gradual loss of CD4
þ T cells, which constitute the
primary target cell type of the virus and which are key players
in adaptive immunity. Immune functions slowly decline,
eventually giving rise to opportunistic infections that
ultimately result in death in nearly all untreated cases. These
processes were ﬁrst thought to be driven by the loss of
infected CD4
þ T cells, killed directly by the cytopathic effect
of the virus. However, accumulating evidence (reviewed in [5])
indicates that the aetiology of HIV infection involves a
generalised chronic hyperactivation of the immune system,
rather than direct cytopathic effects. In addition to infected
CD4
þT cells, the turnover of uninfected CD4
þT cells, CD8
þT
cells, and B cells is also elevated, and persistent activation is
probably responsible for the dysfunction and apoptotic death
of immune cells. The immediate decline of activation markers
(e.g., the percentage of dividing CD4
þ and CD8
þ T cells [6],
and the frequency of antibody-secreting cells [7]) after the
initiation of effective antiretroviral therapy indicates that
hyperactivation is induced by the virus itself, rather than by a
homeostatic mechanism. Natural hosts of SIV, however, show
hardly any sign of immune hyperactivation despite high virus
levels, which may be their key to benign infection [2]. We here
propose the ‘‘integration hypothesis’’, claiming that the
evolutionary pathway to peaceful coexistence may have
involved the integration of retroviral elements into the
germline of the hosts, and the subsequent expression of
retroviral antigens during the maturation of host
lymphocytes to induce partial tolerance to the host-speciﬁc
viruses. Mammalian genomes have long been known to
contain a large number of retrovirus-derived sequences [8],
and HIV-1 proviral DNA has been found in the sperm cells of
individuals who are infected [9], which demonstrates the
possibility of germline integration. Natural hosts of SIV
infections may thus have acquired germline-integrated SIV
elements that could be expressed during the negative
selection of T cells and/or B cells in the thymus [10] and the
bone marrow [11], respectively. Once their antigen speciﬁcity
has been determined by the rearrangement of their receptor
genes, immature T cells spend about one to two weeks in the
thymus [12], while immature B cells spend one to three days
in the bone marrow [13], where they are exposed to contact
with ‘‘self’’ antigens. Those cells that react to the presented
antigens are deleted or anergised (or B cells can be rescued by
changing their speciﬁcity by further receptor editing). The
production of naı ¨ve lymphocytes continues throughout the
lifetime of the individual (although thymic output decreases
with age); therefore, negative selection also operates lifelong.
This mechanism serves normally to remove lymphocytes that
would react to self antigens, but would also operate on
retrovirus-derived antigens expressed at the sites of negative
selection. The thymic expression of the endogenous mouse
mammary tumour virus has indeed been shown to induce
tolerance [14], and retrovirus-transduced genes expressed by
bone marrow–derived cells were able to inhibit B cell
responses to the transduced genes in mice [15]. Alternatively,
the thymic expression of SIV-derived antigens could generate
regulatory T cells that could downregulate peripheral
responses to these elements [16]. Both mechanisms would
inhibit antigen-speciﬁc SIV-induced processes that
contribute to chronic immune hyperactivation in nonnatural
SIV and HIV infections.
Most germline retroviral integrations are probably purged
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and/or bone marrow–speciﬁc expression of those SIV
antigens that are responsible for chronic hyperactivation
would be beneﬁcial for the host, and would therefore be
conserved by natural selection. Considering that neonatal
HIV infection by vertical transmission does not result in
immune tolerance and inhibition of immune hyperactivation
in humans, efﬁcient tolerance induction probably requires
the expression of a speciﬁc subset of viral antigens under
appropriate conditions. Finally, efﬁcient tolerance induction
by host genomic elements depends on low variability of the
targeted viral antigens. In the SIV hosts with long
coevolutionary history, we therefore predict the thymic- and/
or bone marrow–speciﬁc expression of conserved SIV-
derived gene fragments. Importantly, immune responses
against viral epitopes not involved in the induction of
chronic immune hyperactivation are likely to be beneﬁcial
for the hosts and are therefore expected to be retained.
Indeed, naturally infected sooty mangabeys do display
humoral and cellular responses against SIVsm [17,18],
although both responses appear to be weaker than the
responses of SIVsm-infected macaques.
The integration hypothesis emphasises the role of host
adaptation in host–SIV coevolution. Reducing indirect harm
to the host is the mutual interest of the host and the virus,
because it extends the lifespan of the host without limiting
the replication of the virus. However, viral evolution towards
decreasing virulence is probably limited by within-host
competition: the lifespan of the host is expected to be
determined by the most aggressive variant in the host [19].
Furthermore, the infection of macaques with SIVsm results in
AIDS-like disease, accompanied by chronic immune
hyperactivation, which suggests that the ‘‘benign’’ virus of
sooty mangabeys has not evolved to avoid hyperactivation. In
fact, several recent cross-species transmissions of SIVs to
nonnatural hosts have resulted in pathogenic infections,
including multiple transmissions of SIVsm to humans (giving
rise to HIV-2 [20]) and Asian macaques [21], and multiple
transmissions of SIV from chimpanzees to humans (giving
rise to HIV-1 [22]) (Figure 1).
At present, our hypothesis remains an intriguing possibility
that requires experimental testing. It is not known if
nonspeciﬁc mechanisms contribute to HIV-induced
hyperactivation, which would limit the efﬁciency of antigen-
speciﬁc tolerance induction. Whole-genome sequencing of
the natural hosts of SIVs should demonstrate the presence of
SIV-related sequences. In addition to actively expressed
sequences involved in tolerance induction, silenced,
nonexpressed gene fragments may also persist in the genome.
Using predicted ancestral HIV-1 subtype B sequences
(obtained from the Los Alamos database [http://hiv-web.lanl.
gov/content/hiv-db/mainpage.html]) and SIVsm sequences
(accession number M31325) of all viral proteins as queries, we
performed translated similarity searches with tBLASTn
against all sequences of primate origin in the complete
‘‘nonredundant’’ and expressed sequence tags databases of
the National Center for Biotechnology Information Entrez
Nucleotide database [24]. We found no genomic signatures of
DOI: 10.1371/journal.ppat.0020015.g001
Figure 1. Evolutionary Relationships of Primate Lentiviruses Based on Maximum-Likelihood Phylogenetic Analysis of Full-Length Pol Protein Sequences
Viruses responsible for natural infections of African primates are denoted by the name of the host species in black. Recent cross-species transmissions
are shown in color: multiple transmissions from chimpanzees and sooty mangabeys have given rise to HIV infections in humans (red), and multiple
transmissions from sooty mangabeys have given rise to nonnatural pathogenic SIV infections in rhesus, pig-tailed, and stumped-tailed macaques of
Asian origin (blue). Aligned complete Pol sequences were downloaded from the Los Alamos database, and the phylogeny was generated with the
PHYLIP package [23].
AGM, African green monkey; RCM, red-capped mangabey
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hosts of SIV infections. This negative result was to be
expected because few sequences are currently available from
the natural hosts of SIVs (chimpanzees are atypical SIV hosts
with low virus loads and infection prevalence, probably more
analogous to human long-term non-progressors). A more
targeted approach would test a cDNA library of the cells
involved in lymphocyte selection in natural hosts of SIVs.
Finally, immune responses against the SIV-related antigenic
patterns that are expressed in the host species should be
difﬁcult to elicit in the natural hosts due to immune
tolerance. Successful breaking of this tolerance by boosted
vaccines should in turn induce AIDS-like disease in infected
animals.
Several years ago, Norley et al. [25] proposed that
immunological tolerance to Gag could be responsible for
avirulent SIV infection in natural hosts, and hypothesized
that such tolerance could be achieved by the expression of
endogenous retroviral elements. Our hypothesis has a
different emphasis: we do not discuss speciﬁc mechanisms
associated with particular viral genes, but focus on the
possible evolutionary scenario that the origin of the
endogenous elements may have been the very viruses that
cause disease in the absence of tolerance.
The integration hypothesis proposes an evolutionary
pathway to benign SIV infections that is technically plausible
given the ability of retroviruses to insert their genetic
material into the germline of the host, and that would not
have been opposed by evolutionary barriers since it serves the
mutual beneﬁt of viruses and hosts. Whether this path was
indeed taken by evolution must still be veriﬁed by
experimental tests that can be performed by current
technology. Whereas we have plenty of examples of viruses
stealing host genes for their beneﬁt, this would be a rare
example of hosts utilising viral genes in the course of
coevolution. “
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